AmerisourceBergen Makes Buy

Pharmaceutical-services provider AmerisourceBergen ( ABC) said its Canadian subsidiary has agreed to acquire the drug distributor Rep-Pharm.

Rep-Pharm distributes drugs mostly to retail pharmacies in Ontario, Quebec and Alberta. While the specific terms of the acquisition weren't disclosed, AmerisourceBergen says Rep-Pharm brought in revenue of more than $600 million in the last 12 months.

After completing the acquisition, AmerisourceBergen said its Canadian pharmaceutical-distribution business will have more than $1.4 billion in annualized sales and occupy the No. 2 position in Canada. "The acquisition also continues AmerisourceBergen's strategic focus on the pharmaceutical supply channel," CEO R. David Yost said in a press release

The deal, which is expected to close by Sept. 30, probably won't be material to earnings. AmerisourceBergen's shares added 7 cents to $41.87 Wednesday.

More from Stocks

Stocks Trade Mixed, Energy Shares Fall on Sharp Drop in Oil Prices

Stocks Trade Mixed, Energy Shares Fall on Sharp Drop in Oil Prices

UAW Officially Files Complaint on Tesla Thanks to CEO Elon Musk

UAW Officially Files Complaint on Tesla Thanks to CEO Elon Musk

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Jim Cramer: Intuit Had a Fantastic Quarter

Jim Cramer: Intuit Had a Fantastic Quarter

Jim Cramer on Foot Locker's Earnings: Nike Is a Buy

Jim Cramer on Foot Locker's Earnings: Nike Is a Buy